Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Levetiracetam
Keppra
Routinely available
SMC (150/04)
29/03/2023
Indication
Epilepsy. See link to SMC advice for full details of restriction.
Therapeutic Area
Central nervous system
Status Description
Routinely available
Formulation
750mg tablets
Comments
-
Link to Advice
Advice Published
10/01/2005
SMC Submission Type
Abbreviated
SMC Status
Restricted